Coronavirus (COVID-19)


Information and updates to help clinical and laboratory staff manage the impact of COVID-19

Text version of image

O- 3.8 days, A- 8.4 days, B- 3.5 days, AB- 7.6 days, O+ 3.6 days, A+ 4.6 days, B+ 9.1 days, AB+ 9.8 days 

This is stock we can issue to hospitals. We’re preparing donations to add to this stock.

If your stock falls to less than 2 days refer to the red cell shortage plan.

Text version of image

O- 1.4 days, A- 1.1 days, B- 1.6 days, AB- 2.9 days, O+ 1.5 days, A+ 1.7 days, B+ 2 days, AB+ 3.9 days 

This is stock we can issue to hospitals. We’re preparing donations to add to this stock.

If your stock falls to 0.5 days or less refer to the platelet shortage plan.

Blood supply updates

26 May

  • We continue to rely on you to keep us updated with any changes in your hospital activity that may result in a change in demand for blood components. Our current assumption is that demand for red cells over the next few months will be higher than those at pre Covid levels
  • We are particularly interested in changes in high blood use surgery e.g. cardiothoracic, vascular, orthopaedic
  • If you do not have this information, we would be grateful if you would contact your Chief Operating Officer / Recovery Leads to provide further information on changes to activity
  • We would also like to know if you have plans to increase your red cell stock levels

Read 26 May update

17 March 

  • Please continue to store any unused CCP pending further information from NHSBT

Read 17 March update

22 February 

  • Intelligence to support demand forecasting 
  • Stock management
  • Maintaining supply of blood components

Read 22 February update 

 

Archive

Read our archived updates

 

Do you or your colleagues want to donate?

Please book an appointment by

Please be aware of the changes to testing and referring for:

Updates relating to: 

  • TAS - clinical and operational
  • Stem cells - NICE rapid guidance on haemopoietic stem cell transplantation 

Survey of blood component requirements in COVID-19 patients 

The aim of the survey is to establish levels of blood component use by swab positive COVID-19 patients admitted to hospital.